 |
answer text |
<p>As part of the NHS Long Term Plan, the National Health Service has committed to
sequencing 500,000 whole genomes by 2023/24.</p><p>During 2019, the NHS will begin
to offer whole genome sequencing (WGS) as part of clinical care for:</p><p>- Seriously
ill children likely to have a rare genetic disorder;</p><p>- People with one of 21
rare conditions where current evidence supports early adoption of WGS as a diagnostic
test;</p><p>- People with specific types of cancer for which there is likely to be
the greatest patient benefit from using WGS – children with cancer, sarcoma and Acute
Myeloid Leukaemia.</p><p> </p><p>As the price of whole genome sequencing falls and
the evidence improves, we envisage that it will be extended to more conditions and
therefore more patients.</p>
|
 |
